Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Iveric Bio Inc (ISEE)  
$39.95 0.00 (0.00%) as of 4:30 Mon 7/10


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 153,922,000
Market Cap: 6.15(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $36.9 - $39.95
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   IVERIC bio is biopharmaceutical company focused on the discovery and development of treatments for retinal diseases with unmet medical needs. Co.'s clinical stage product candidate, Zimura® (avacincaptad pegol), a complement C5 inhibitor. Co. is targeting the following diseases with Zimura: Geographic Atrophy, intermediate age-related macular degeneration, and autosomal recessive Stargardt disease. In addition to Zimura, Co. is developing its preclinical product candidate IC-500, a high temperature requirement A serine peptidase 1 protein inhibitor, for GA and potentially other age-related retinal diseases.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 40,000 561,286
Total Sell Value $0 $0 $1,546,400 $15,378,126
Total People Sold 0 0 1 5
Total Sell Transactions 0 0 2 30
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 468
  Page 18 of 19  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Peacock Bruce CFO & CBO   •       –      –    2014-07-01 4 AS $40.88 $317,832 D/D (7,739) 0     -
   Peacock Bruce CFO & CBO   •       –      –    2014-07-01 4 OE $1.65 $12,785 D/D 7,739 7,739     -
   Galakatos Nicholas Director   –       •      –    2014-06-16 4 A $44.24 $102,104 I/I 2,308 4,808     -
   Galakatos Nicholas Director   –       •      –    2014-06-16 4 A $44.24 $238,227 D/D 5,385 7,885     -
   Galakatos Nicholas Director   –       •      –    2014-06-16 4 D $44.24 $50,602,515 I/I (1,143,844) 1,554,744     -
   Galakatos Nicholas Director   –       •      –    2014-06-16 4 S $44.00 $681,208 I/I (15,482) 2,698,588     -
   Galakatos Nicholas Director   –       •      –    2014-06-13 4 S $44.01 $3,621,225 I/I (82,277) 2,714,070     -
   Galakatos Nicholas Director   –       •      –    2014-06-12 4 S $44.51 $2,101,657 I/I (47,217) 2,796,347     -
   Wheeler Kurt 10% Owner   –       –       •   2014-06-11 4 S $44.32 $22,160 I/I (500) 4,500     -
   Wheeler Kurt 10% Owner   –       –       •   2014-06-11 4 S $44.53 $1,301,074 D/D (29,217) 2,843,564     -
   Wheeler Kurt 10% Owner   –       –       •   2014-06-10 4 S $44.66 $5,266,977 D/D (116,904) 2,872,781     -
   Wheeler Kurt 10% Owner   –       –       •   2014-06-09 4 S $46.02 $3,023,963 D/D (65,059) 2,989,685     -
   Patel Samir Chandrakant President   •       •      –    2014-06-04 4 D $0.00 $0 I/I (384,984) 0     -
   Sv Life Sciences Fund Iv Strategic Partners, L. P. 10% Owner   –       –       •   2014-06-04 4 S $42.54 $27,891,138 D/D (655,645) 84,325     -
   Sv Life Sciences Fund Iv Strategic Partners, L. P. 10% Owner   –       –       •   2014-06-04 4 S $42.54 $55,782,277 I/I (1,311,290) 3,054,458     -
   Peacock Bruce CFO & CBO   •       –      –    2014-06-03 4 AS $40.41 $205,849 D/D (5,094) 0     -
   Peacock Bruce CFO & CBO   •       –      –    2014-06-03 4 OE $1.65 $8,415 D/D 5,094 5,094     -
   Sv Life Sciences Fund Iv Strategic Partners, L. P. 10% Owner   –       –       •   2014-06-03 4 S $40.81 $20,728,338 D/D (507,923) 102,425     -
   Sv Life Sciences Fund Iv Strategic Partners, L. P. 10% Owner   –       –       •   2014-06-03 4 S $40.81 $41,456,675 I/I (1,015,846) 3,710,103     -
   Patel Samir Chandrakant President   •       •      –    2014-06-02 4 AS $39.88 $1,112,358 D/D (27,873) 76,599     -
   Peacock Bruce CFO & CBO   •       –      –    2014-06-02 4 AS $39.88 $353,064 D/D (8,837) 0     -
   Peacock Bruce CFO & CBO   •       –      –    2014-06-02 4 OE $1.65 $14,599 D/D 8,837 8,837     -
   Guyer David R Chief Executive Officer   •       •      –    2014-06-02 4 AS $39.88 $1,014,551 D/D (25,417) 0     -
   Guyer David R Chief Executive Officer   •       •      –    2014-06-02 4 OE $10.03 $135,666 D/D 13,526 25,417     -
   Sv Life Sciences Fund Iv Strategic Partners, L. P. 10% Owner   –       –       •   2014-06-02 4 S $39.91 $4,547,745 D/D (113,950) 116,447     -
  468 Records found
  Previous  10  11  12  13  14  15  16  17  18  19   
  Page 18 of 19
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us